<DOC>
	<DOCNO>NCT01615913</DOCNO>
	<brief_summary>This study explore optimization anti‐onychomycosis patch various formulation content ( three patch group : 3 % , 6 % 8 % terbinafine ( contain 3‐mg , 6‐mg 8‐mg/patch terbinafine , respectively ) combine fixed 2 % ketoconazole ( contain 2‐mg ketoconazole/patch ) safety profile .</brief_summary>
	<brief_title>Optimizing Treatment Toenail Onychomycosis Using New Transdermal Patch Combined With Terbinafine/Ketoconazole</brief_title>
	<detailed_description>This study explore optimization anti‐onychomycosis patch various formulation content ( three patch group : 3 % , 6 % 8 % terbinafine ( contain 3‐mg , 6‐mg 8‐mg/patch terbinafine , respectively ) combine fixed 2 % ketoconazole ( contain 2‐mg ketoconazole/patch ) safety profile . At least 18 patient ( age : 20 75 year old ) one two foot toenail infect simultaneously need complete whole study . Patients assign one patch group . The patient one infect toenail also apply one patch foot uninfected toenail . The patch apply foot dorsal site leave two consecutive day . Totally six patch use week . The duration therapy 24 week . The patient ' blood sample toenail clipping collect every 8 week analyze well safety profile . The appropriate patch formulation select drug content residue toenail . The safety profile also present discussed various anti‐onychomycosis patch formulation .</detailed_description>
	<mesh_term>Onychomycosis</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<mesh_term>Terbinafine</mesh_term>
	<criteria>Male female 20‐75 year age Fungal infection one toenail confirm use method histopathological examination periodic acid‐Schiff ( PAS ) staining ( Yang JH , et al. , 2007 ) The toenail infection due dermatophyte , yeast mixed infection ( dermatophyte non‐dermatophyte ) The target toenail area must least 25 % 75 % disease involvement without spike Patients agree sign inform consent form Using kind systemic topical nail lacquer solution antifungal drug within 6 month screen visit ; use topical antifungal agent , ointment , cream , gel , solution , suspension , oil lotion form , within two week screen visit Patients target toenail involve matrix ( lunula ) less 2 mm clear ( unaffected ) nail plate length beyond proximal fold Presence dermatophytoma target nail Using professional pedicure application nail polish product nail cosmetic toenail screen visit Patients unwilling provide nail clipping Patients previously report allergic topical systemic terbinafine ketoconazole therapy Known pregnancy plan get pregnant within study duration lactation time enrollment Unconsciousness inability understand form study project .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>onychomycosis</keyword>
	<keyword>terbinafine</keyword>
	<keyword>ketoconazole</keyword>
	<keyword>transdermal topical therapy</keyword>
</DOC>